We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cisco
CSCO
$450B
| $18.5M | 0.39% |
+666,309
| New | +$17.2M |
|
77
FedEx
FDX
$74.5B
| $18.1M | 0.38% |
+104,247
| New | +$17.6M |
|
78
Illumina
ILMN
$29.4B
| $17.9M | 0.37% |
+99,481
| New | +$17.5M |
|
79
Eli Lilly
LLY
$1.07T
| $17.8M | 0.37% |
+257,473
| New | +$17.4M |
|
80
SLB Ltd
SLB
$77.8B
| $17.6M | 0.37% |
+205,630
| New | +$18.9M |
|
81
Zimmer Biomet
ZBH
$17.7B
| $17.3M | 0.36% |
+157,372
| New | +$16.6M |
|
|
CMA
82
DELISTED
Comerica
CMA
| $17.3M | 0.36% |
+368,440
| New | +$17.3M |
|
83
Northrop Grumman
NOC
$77B
| $17.1M | 0.36% |
+116,280
| New | +$15.9M |
|
84
Martin Marietta Materials
MLM
$33.6B
| $17M | 0.36% |
+154,318
| New | +$18.2M |
|
85
BioMarin Pharmaceuticals
BMRN
$11.5B
| $16.6M | 0.35% |
+183,703
| New | +$15.3M |
|
|
BRCM
86
DELISTED
BROADCOM CORP CL-A
BRCM
| $16.6M | 0.35% |
+382,895
| New | +$15.7M |
|
|
AVP
87
DELISTED
Avon Products, Inc.
AVP
| $16.5M | 0.34% |
+1,753,656
| New | +$18.1M |
|
88
Mastercard
MA
$477B
| $16.3M | 0.34% |
+188,972
| New | +$15.4M |
|
|
JNPR
89
DELISTED
Juniper Networks
JNPR
| $16.3M | 0.34% |
+728,924
| New | +$15.5M |
|
90
Public Service Enterprise Group
PEG
$39.8B
| $16.2M | 0.34% |
+392,383
| New | +$15.8M |
|
|
EMC
91
DELISTED
EMC CORPORATION
EMC
| $16.2M | 0.34% |
+545,241
| New | +$15.9M |
|
92
Royal Bank of Canada
RY
$291B
| $16.2M | 0.34% |
+234,032
| New | +$16.6M |
|
93
Procter & Gamble
PG
$343B
| $16.1M | 0.34% |
+177,021
| New | +$15.6M |
|
|
RTN
94
DELISTED
Raytheon Company
RTN
| $16.1M | 0.34% |
+148,608
| New | +$15.3M |
|
95
Western Digital
WDC
$179B
| $16M | 0.33% |
+191,060
| New | +$14.4M |
|
96
Incyte
INCY
$23.5B
| $15.8M | 0.33% |
+215,868
| New | +$14.1M |
|
|
ESRX
97
DELISTED
Express Scripts Holding Company
ESRX
| $15.6M | 0.33% |
+184,535
| New | +$14.4M |
|
98
Lowe's Companies
LOW
$116B
| $15.2M | 0.32% |
+220,531
| New | +$13.2M |
|
99
NVIDIA
NVDA
$5.01T
| $15M | 0.31% |
+29,978,520
| New | +$14.6M |
|
100
Chevron
CVX
$388B
| $14.9M | 0.31% |
+132,869
| New | +$15.1M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.